Indirubin-3′-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain
- 1 May 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 70, 396-407
Abstract
No abstract availableKeywords
Funding Information
- University Grants Commission
This publication has 72 references indexed in Scilit:
- Pharmacological Administration of the Isoflavone Daidzein Enhances Cell Proliferation and Reduces High Fat Diet-Induced Apoptosis and Gliosis in the Rat HippocampusPLOS ONE, 2013
- Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adultsArchives of Medical Science, 2011
- Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?Neuropsychopharmacology, 2010
- Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)Trends in Immunology, 2010
- An Overview of APP Processing Enzymes and ProductsNeuroMolecular Medicine, 2009
- Glycogen synthase kinase‐3 negatively regulates anti‐inflammatory interleukin‐10 for lipopolysaccharide‐induced iNOS/NO biosynthesis and RANTES production in microglial cellsImmunology, 2009
- Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicityCellular Signalling, 2009
- Hypothalamic IKKβ/NF-κB and ER Stress Link Overnutrition to Energy Imbalance and ObesityCell, 2008
- Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and TherapeuticsNeurochemical Research, 2006
- The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathwaysProgress in Neurobiology, 2006